Publications of I. Nakchbandi
All genres
Journal Article (40)
21.
Journal Article
54 (Suppl. 1), p. 1040 - 1040 (2011)
FIBRONECTIN IN THE LIVER MODIFIES SEVERITY OF LIVER FIBROSIS. Journal of Hepatology 22.
Journal Article
106 (2), pp. 355 - 356 (2011)
Commentary on Grey et al. (2011): Does methadone maintenance therapy adversely affect bone mass? Addiction 23.
Journal Article
48 (1 Sp. Iss.), p. S50 - S50 (2011)
The role of fibronectin originating from different sources on breast cancer metastasis development and bone remodeling. Bone 24.
Journal Article
111 (4), pp. 1020 - 1034 (2010)
Fibronectin Inhibits Osteoclastogenesis While Enhancing Osteoclast Activity via Nitric Oxide and Interleukin-1 beta-Mediated Signaling Pathways. Journal of Cellular Biochemistry 25.
Journal Article
47 (Suppl. 2), pp. S263 - S264 (2010)
The role of fibronectin in the bone marrow metastatic niches. Bone 26.
Journal Article
25 (4), pp. 706 - 715 (2010)
Circulating Fibronectin Affects Bone Matrix, Whereas Osteoblast Fibronectin Modulates Osteoblast Function. Journal of Bone and Mineral Research 27.
Journal Article
45 (3), pp. 349 - 356 (2010)
Circulating fibronectin isoforms predict the degree of fibrosis in chronic hepatitis C. Scandinavian Journal of Gastroenterology 28.
Journal Article
6 (11), pp. 660 - 670 (2009)
Current understanding of osteoporosis associated with liver disease. Nature Reviews Gastroenterology & Hepatology 29.
Journal Article
23 (Suppl. Suppl. S), p. S163 - S163 (2008)
Circulating Fibronectin Affects Bone Matrix. Journal of Bone and Mineral Research 30.
Journal Article
17 (3), pp. 285 - 290 (2008)
Prospective study on warfarin and regional chemotherapy in patients with pancreatic carcinoma. Journal of Gastrointestinal and Liver Diseases 31.
Journal Article
27 (7), pp. 609 - 618 (2008)
Role for beta 1 integrins in cortical osteocytes during acute musculoskeletal disuse. Matrix Biology 32.
Journal Article
23 (8), pp. 1278 - 1286 (2008)
Isoform of fibronectin mediates bone loss in patients with primary biliary cirrhosis by suppressing bone formation. Journal of Bone and Mineral Research 33.
Journal Article
5 (8), pp. 445 - 455 (2008)
Coagulation, anticoagulation and pancreatic carcinoma. Nature Clinical Practice Gastroenterology & Hepatology 34.
Journal Article
45 (12), pp. 3330 - 3337 (2008)
Lipopolysaccharides (LPS) induce the differentiation of human monocytes to osteoclasts in a tumour necrosis factor (TNF) alpha-dependent manner: A link between infection and pathological bone resorption. Molecular Immunology 35.
Journal Article
93 (3), pp. 967 - 973 (2008)
The role of the receptor activator of nuclear factor-kappa B ligand/osteoprotegerin cytokine system in primary hyperparathyroidism. Journal of Clinical Endocrinology & Metabolism 36.
Journal Article
82 (Suppl. Suppl. 1), p. S97 - S97 (2008)
Circulating plasma fibronectin is needed for a normal bone density. Calcified Tissue International 37.
Journal Article
82 (Suppl. Suppl. 1), p. S97 - S97 (2008)
Osteoblast fibronectin affects their behavior in vivo. Calcified Tissue International 38.
Journal Article
82 (Suppl. Suppl. 1), p. S106 - S106 (2008)
Bone loss in patients with primary biliary cirrhosis is caused by a fibronectin isoform. Calcified Tissue International 39.
Journal Article
41 (9), pp. 1095 - 1104 (2006)
Effects of low-dose warfarin and regional chemotherapy on survival in patients with pancreatic carcinoma. Scandinavian Journal of Gastroenterology 40.
Journal Article
22, pp. 591 - 621 (2006)
What mouse mutants teach us about extracellular matrix function. Ann. Rev. Cell Dev. Biol.